CollPlant Biotechnologies Ltd (CLGN) › Shareholders' EquityCollPlant Biotechnologies Ltd (CLGN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $5.17M2018: $5.42M2019: $4.09M2020: $4.48M2021: $45.12M2022: $32.28M2023: $28.34M2024: $13.46M2025: $6.08M$6.08M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$6.08M-54.8%2024$13.46M-52.5%2023$28.34M-12.2%2022$32.28M-28.5%2021$45.12M+907.8%2020$4.48M+9.5%2019$4.09M-24.6%2018$5.42M+4.8%2017$5.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share